Skip to main navigation Skip to search Skip to main content

A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)

  • Mignon L. Loh
  • , Sarah K. Tasian
  • , Karen R. Rabin
  • , Patrick Brown
  • , Daniel Magoon
  • , Joel M. Reid
  • , Xuejun Chen
  • , Charlotte H. Ahern
  • , Brenda J. Weigel
  • , Susan M. Blaney

Research output: Contribution to journal › Article › peer-review

118   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science